DBM-819
| Code | Size | Price |
|---|
| TAR-T31219-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
DBM-819 is a biochemical.
CAS:
331686-58-9
Formula:
C23H27N3O2
Molecular Weight:
377.488
Purity:
0.98
SMILES:
COc1ccc(N2CCc3c2c2cccc(C)c2nc3NCCCO)c(C)c1
References
1. Kim EJ, Lee MH, Kim SH, Kim SO, Lee DH, Lim HL, Lee HS, Lee MG. Determination of a new reversible proton pump inhibitor, DBM-819, in human plasma and urine, and rat tissue homogenates by high-performance liquid chromatography. J Pharm Biomed Anal. 2002 Oct 15;30(3):511-8. PubMed PMID: 12367675.
2. Choi SJ, Ji HY, Lee HY, Lee DH, Lim H, Lee HS. In vitro metabolism of a new H(+)/K(+) ATPase inhibitor DBM-819 in liver microsomes using HPLC and electrospray mass spectrometry. Biomed Chromatogr. 2001 Dec;15(8):503-6. PubMed PMID: 11748683.
3. Kim EJ, Kim SO, Lee DH, Lim H, Lee MG. Dose-dependent pharmacokinetics of a new reversible proton pump inhibitor, DBM-819, after intravenous and oral administration to rats: hepatic first-pass effect. Biopharm Drug Dispos. 2001 Apr;22(3):119-28. PubMed PMID: 11745914.
4. Cheon HG, Lee SS, Lim H, Lee DH. Pharmacological properties of a newly synthesized H(+)/K(+) ATPase inhibitor, 1-(2-methyl-4-methoxyphenyl)-4-. Eur J Pharmacol. 2001 Jan 5;411(1-2):187-192. PubMed PMID: 11137875.